News and Content
The Latest News from Agilex Biolabs
Author By Agilex BiolabsPosted on
As Agilex Biolabs continues its global expansion and corporate evolution as part of the Healius network, Stephen McIntyre has been selected to take the position of Chief Executive Officer.
Author By Agilex BiolabsPosted on
Rescue studies are a particular point of strength at Agilex Biolabs, where the bioanalytical experts are driven to solve challenges presented by what we call “the weird and wonderful”.
Author By Agilex BiolabsPosted on
On November 21, 2022, Agilex Biolabs was named this year’s winner for the Editor’s Choice Award for “Top company in clinical research-based development” in BioSpectrum Asia Excellence Awards.
Author By Agilex BiolabsPosted on
Agilex Biolabs, the leading bioanalytical laboratory supporting Australian clinical trials, has established its first satellite processing unit staffed with highly specialised technicians on the fifth floor of the CMAX Clinical Research facility in Adelaide, SA.
Author By Agilex BiolabsPosted on
Agilex Biolabs has expanded its capacity to better serve the biotech, pharmaceutical and animal health industry with the opening of its new in-vivo testing facility.
Author By Agilex BiolabsPosted on
Circulating tumor DNA (ctDNA) is tumor-deriver fragmented DNA which originates either directly from the tumor or from circulating tumor cells.
Author By Agilex BiolabsPosted on
Immunogenicity assessment of biotherapeutics is a regulatory requirement and key parameter for assessing the safety and efficacy of a drug candidate.
Author By Agilex BiolabsPosted on
Immunogenicity assessment is a critical safety attribute for biotherapeutics undergoing clinical development.
Author By Agilex BiolabsPosted on
Dr. Kurt Sales Appointed as Chief Scientific Officer at Agilex Biolabs Kurt Sales as Chief Scientific Officer will lead future...
Author By Agilex BiolabsPosted on
Learn how to improve Bioanalytical clinical outcomes by performing MetID characterisation. Leading experts Heather Heading and...
Author By Agilex BiolabsPosted on
Large Molecule Facility Doubles Size of Australia’s Top Bioanalytical Laboratory Agilex Biolabs has launched its new laborato...
Author By Agilex BiolabsPosted on
Agilex Biolabs provides world-class toxicology services via its purpose-built GLP compliant facility in Brisbane, Australia. In co...
Author By Agilex BiolabsPosted on
This year, we at Agilex Biolabs celebrate our 25th year supporting Biotechs’ drug development programs ...
Author By Agilex BiolabsPosted on
Agilex Biolabs Pty Ltd has been purchased by one of Australia’s leading healthcare companies, Healius Limited
Author By Agilex BiolabsPosted on
With increasingly novel drug development programs, meaningful collection of subject samples has never been more relevant. Don’t let potential analyte instability mislead your program as it gets underway, causing costly time delays
Author By Agilex BiolabsPosted on
Agilex Biolabs Congratulates VGI Health Technology Limited for successful filing of a new PCT Patent Application on Transmucosal Delivery of Tocotrienols
Author By Agilex BiolabsPosted on
With the integration of leading toxicology company TetraQ into Agilex Biolabs’ service offering, Agilex Biolabs is now the only...
Author By Agilex BiolabsPosted on
Meet the Scientists series - Meer Dr Jason Geue, R& D Manager at Agilex Biolabs.
Author By Agilex BiolabsPosted on
Agilex Biolabs, Australia’s most experienced and technologically advanced bioanalytical laboratory and the only biolab in the region with a dedicated toxicology unit, has been selected as a finalist for the Most Successful Early Phase Research (Preclinical & Phase I) category in the Citeline Awards 2021.
Author By Agilex BiolabsPosted on
https://youtu.be/dnyLFRPLEJo...
Author By Agilex BiolabsPosted on
Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials is partnering with Endpoints News to share the latest on “Non-clinical and clinical pathways for rapid vaccine development in Australia”, in a webinar hosted by Endpoints News Editor Arsalan Arif.
Author By Agilex BiolabsPosted on
Agilex Biolabs, Australia’s largest and most technologically advanced regulated bioanalytical laboratory for clinical trials is showcasing its new $1.5m vaccine and immunobiology laboratory at BIO Asia Taiwan 2021. The facility, the most sophisticated in APAC, is designed for biotechs and pharma from around the world for advanced clinical research including RNA vaccines, siRNA/miRNA clinical targets and gene therapy studies.
Over the past 2 years, Agilex Biolabs has invested more than $3.5m in technology and systems at the APAC headquarters in Adelaide.
Over the past 2 years, Agilex Biolabs has invested more than $3.5m in technology and systems at the APAC headquarters in Adelaide.
Author By Agilex BiolabsPosted on
Agilex Biolabs, Australia’s largest and most technologically advanced regulated bioanalytical laboratory for clinical trials today announced that the Premier of South Australia the Hon Steven Marshall MP has launched its new $1.5m vaccine and immuno-biology laboratory. The facility, the most sophisticated in APAC, will attract biotechs and pharma from around the world for advanced clinical research.
Over the past 2 years, Agilex Biolabs has invested more than $3.5m in technology and systems at the APAC headquarters in Adelaide.
Over the past 2 years, Agilex Biolabs has invested more than $3.5m in technology and systems at the APAC headquarters in Adelaide.